Yimei Feng

1.1k total citations
44 papers, 671 citations indexed

About

Yimei Feng is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Yimei Feng has authored 44 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 13 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Yimei Feng's work include Hematopoietic Stem Cell Transplantation (17 papers), Platelet Disorders and Treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Yimei Feng is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Platelet Disorders and Treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Yimei Feng collaborates with scholars based in China, United States and Ireland. Yimei Feng's co-authors include Xi Zhang, Zhongmin Zou, Kaniel Cassady, Shijie Yang, Xiaoping Li, Xinze Ran, Lilong Zhang, Tao Wang, Chunmeng Shi and Huiqin Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal Of Pathology.

In The Last Decade

Yimei Feng

34 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yimei Feng China 12 242 200 190 112 99 44 671
Meenakshi Gaur United States 13 305 1.3× 108 0.5× 180 0.9× 55 0.5× 57 0.6× 22 651
Patrícia Vianna Bonini Palma Brazil 14 124 0.5× 89 0.4× 197 1.0× 43 0.4× 77 0.8× 31 475
Keith M. Blechman United States 9 285 1.2× 63 0.3× 60 0.3× 184 1.6× 72 0.7× 13 807
Juan Luis Callejas‐Valera United States 12 299 1.2× 42 0.2× 56 0.3× 88 0.8× 121 1.2× 19 693
Keon-Il Im South Korea 14 114 0.5× 76 0.4× 226 1.2× 28 0.3× 156 1.6× 29 482
Mario Ricciardi Italy 10 228 0.9× 59 0.3× 267 1.4× 19 0.2× 111 1.1× 15 700
Jianping Guo China 18 320 1.3× 91 0.5× 186 1.0× 21 0.2× 357 3.6× 50 964
África González‐Murillo Spain 16 291 1.2× 53 0.3× 98 0.5× 35 0.3× 60 0.6× 39 670
Takehiko Yamazaki Japan 12 307 1.3× 28 0.1× 211 1.1× 52 0.5× 86 0.9× 20 813
Aleksandra Jauković Serbia 16 209 0.9× 32 0.2× 316 1.7× 26 0.2× 100 1.0× 38 681

Countries citing papers authored by Yimei Feng

Since Specialization
Citations

This map shows the geographic impact of Yimei Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimei Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimei Feng more than expected).

Fields of papers citing papers by Yimei Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimei Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimei Feng. The network helps show where Yimei Feng may publish in the future.

Co-authorship network of co-authors of Yimei Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yimei Feng. A scholar is included among the top collaborators of Yimei Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimei Feng. Yimei Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shengwang, Nan Li, Qiang Xing, et al.. (2025). SIL-TAL1-Positive Adult T-ALL with t(11;14)(p15;q11.2): A Rare Case Report Highlighting Prognostic Challenges and Treatment Implications. Journal of Inflammation Research. Volume 18. 2339–2347.
2.
3.
Wang, Dan, et al.. (2025). Real-world experience of hetrombopag in immune thrombocytopenia treatment: a retrospective cohort study. European journal of medical research. 30(1). 574–574.
4.
5.
Gou, Yang, Ping Wang, Yimei Feng, et al.. (2024). A Case of Adult Hereditary Spherocytosis Concomitant with Gilbert Syndrome Caused by Mutations in SPTB and UGT1A1. Journal of Inflammation Research. Volume 17. 5977–5983. 1 indexed citations
6.
Wang, Dan, Hanqing Zeng, Zhongmin Zou, et al.. (2023). Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantation. Transplant Immunology. 81. 101948–101948. 1 indexed citations
7.
Zhang, Yun, Dan Wang, Kaniel Cassady, et al.. (2023). Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia. Platelets. 34(1). 2277831–2277831. 3 indexed citations
8.
Wang, Lu, Peiyan Kong, Cheng Zhang, et al.. (2023). Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Annals of Hematology. 102(6). 1569–1579. 7 indexed citations
9.
Zhu, Lidan, Jia Liu, Peiyan Kong, et al.. (2022). Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 13. 910893–910893. 8 indexed citations
10.
Zhou, Yi, Jun Ye, Xiao‐Cheng Wu, et al.. (2021). Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study. BMC Infectious Diseases. 21(1). 760–760. 7 indexed citations
11.
Wang, Zheng, Yimei Feng, Lei Huang, et al.. (2021). Single‐cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity. SHILAP Revista de lepidopterología. 11(12). e650–e650. 95 indexed citations
12.
Feng, Yimei, Ping Wang, Wen Zhu, et al.. (2020). Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study. Frontiers in Medicine. 7. 110–110. 31 indexed citations
13.
Feng, Yimei, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, & Xi Zhang. (2019). TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair. Frontiers in Oncology. 9. 210–210. 84 indexed citations
14.
Li, Xiaoping, Ting Chen, Qiangguo Gao, et al.. (2019). A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD. JCI Insight. 4(16). 14 indexed citations
15.
Sun, Jie, Ying‐Hui Zhu, Zonghui Ding, et al.. (2016). TET2 Activity Is Modulated By SIRT1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome. Blood. 128(22). 1053–1053.
16.
Wang, Tao, Yimei Feng, Huiqin Sun, et al.. (2012). miR-21 Regulates Skin Wound Healing by Targeting Multiple Aspects of the Healing Process. American Journal Of Pathology. 181(6). 1911–1920. 155 indexed citations
17.
Feng, Yimei, Zhongmin Zou, Lei Gao, et al.. (2012). Umbilical Cord Blood-Derived Stromal Cells Regulate Megakaryocytic Proliferation and Migration Through SDF-1/PECAM-1 Pathway. Cell Biochemistry and Biophysics. 64(1). 5–15. 2 indexed citations
18.
Zhang, Xi, Cheng Zhang, Lei Gao, et al.. (2011). Human Umbilical Cord Blood-Derived Stromal Cells Are Superior to Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Inducing Myeloid Lineage Differentiation In Vitro. Stem Cells and Development. 21(9). 1429–1440. 10 indexed citations
19.
Feng, Yimei, Xinghua Chen, & Lei Gao. (2010). Knockdown of miR-21 as a Novel Approach for Leukemia Therapy. Journal of the Formosan Medical Association. 109(9). 621–623. 6 indexed citations
20.
Gao, Lei, Yimei Feng, Xi Zhang, et al.. (2010). Human umbilical cord blood-derived stromal cells: Multifaceted regulators of megakaryocytopoiesis. Cell Cycle. 9(7). 1342–1353. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meenakshi Gaur Breakdown of academic impact, for papers by Patrícia Vianna Bonini Palma Breakdown of academic impact, for papers by Keith M. Blechman Breakdown of academic impact, for papers by Juan Luis Callejas‐Valera Breakdown of academic impact, for papers by Keon-Il Im Breakdown of academic impact, for papers by Mario Ricciardi Breakdown of academic impact, for papers by Jianping Guo Breakdown of academic impact, for papers by África González‐Murillo Breakdown of academic impact, for papers by Takehiko Yamazaki Breakdown of academic impact, for papers by Aleksandra Jauković
Rankless by CCL
2026